These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 29692177)

  • 1. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
    Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
    ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor-sensitive biological metal-organic complex for drug delivery and cancer therapy.
    Jiang Z; Wang T; Yuan S; Wang M; Qi W; Su R; He Z
    J Mater Chem B; 2020 Aug; 8(32):7189-7196. PubMed ID: 32618980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
    Wei Q; Wu Y; Liu F; Cao J; Liu J
    J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
    Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Targeting of a Drug Delivery System through Postsynthetic Modification of Curcumin@N
    Alves RC; Schulte ZM; Luiz MT; Bento da Silva P; Frem RCG; Rosi NL; Chorilli M
    Inorg Chem; 2021 Aug; 60(16):11739-11744. PubMed ID: 34101467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
    Wu MX; Yang YW
    Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charge Transport in Zirconium-Based Metal-Organic Frameworks.
    Kung CW; Goswami S; Hod I; Wang TC; Duan J; Farha OK; Hupp JT
    Acc Chem Res; 2020 Jun; 53(6):1187-1195. PubMed ID: 32401008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-Organic Framework (MOF)-based Nanomaterials for Biomedical Applications.
    Luo Z; Fan S; Gu C; Liu W; Chen J; Li B; Liu J
    Curr Med Chem; 2019; 26(18):3341-3369. PubMed ID: 29446726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-Organic Framework Derived Nanozymes in Biomedicine.
    Wang D; Jana D; Zhao Y
    Acc Chem Res; 2020 Jul; 53(7):1389-1400. PubMed ID: 32597637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.
    Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM
    Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
    Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
    Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
    Carrillo-Carrión C
    Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-Organic Framework (MOF)-Based Drug Delivery.
    Cao J; Li X; Tian H
    Curr Med Chem; 2020; 27(35):5949-5969. PubMed ID: 31215374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise Synthesis of Metal-Organic Frameworks.
    Bosch M; Yuan S; Rutledge W; Zhou HC
    Acc Chem Res; 2017 Apr; 50(4):857-865. PubMed ID: 28350434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis.
    Li B; Ashrafizadeh M; Jiao T
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129391. PubMed ID: 38242413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in Metal-Organic Frameworks as nanocarriers for triggered release of anticancer drugs: Brief history, biomedical applications, challenges and future perspective.
    Fatima SF; Sabouni R; Garg R; Gomaa H
    Colloids Surf B Biointerfaces; 2023 May; 225():113266. PubMed ID: 36947901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery.
    Abánades Lázaro I; Haddad S; Rodrigo-Muñoz JM; Marshall RJ; Sastre B; Del Pozo V; Fairen-Jimenez D; Forgan RS
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):31146-31157. PubMed ID: 30136840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-Organic Framework-Templated Biomaterials: Recent Progress in Synthesis, Functionalization, and Applications.
    Begum S; Hassan Z; Bräse S; Wöll C; Tsotsalas M
    Acc Chem Res; 2019 Jun; 52(6):1598-1610. PubMed ID: 30977634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.